Xspray Pharma is a startup based in Sweden, 2 tracked investors.
Xspray Pharma is a startup based in Sweden. Brouky records 2 investors associated with the company.
Xspray Pharma develops improved amorphous formulations of marketed drugs, primarily protein kinase inhibitors (PKIs), using a patented spray-drying technology to create product candidates for oncology. The company aims to offer formulation variants that can enter market after original drug substance patents expire and that retain patient-beneficial properties versus generic crystalline forms.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.